|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-3-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Osteoprotegerin (OPG) may be implicated in the pathogenesis of heart failure (HF), and circulating levels predict survival in patients with postinfarction HF. Our primary goal was to determine whether OPG provided independent prognostic information in patients with chronic HF, and to examine its potential interactions with statin therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1941-3297
|
|
pubmed:author |
pubmed-author:AukrustPålP,
pubmed-author:BöhmMichaelM,
pubmed-author:DahlChristen PCP,
pubmed-author:GoudevAssenA,
pubmed-author:GullestadLarsL,
pubmed-author:HultheJohannesJ,
pubmed-author:KjekshusJohnJ,
pubmed-author:LindbergMagnusM,
pubmed-author:MachFrançoisF,
pubmed-author:UelandThorT,
pubmed-author:WikstrandJohnJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
145-52
|
|
pubmed:dateRevised |
2011-10-27
|
|
pubmed:meshHeading |
pubmed-meshheading:21216833-Aged,
pubmed-meshheading:21216833-Aged, 80 and over,
pubmed-meshheading:21216833-Biological Markers,
pubmed-meshheading:21216833-Chronic Disease,
pubmed-meshheading:21216833-Europe,
pubmed-meshheading:21216833-Female,
pubmed-meshheading:21216833-Fluorobenzenes,
pubmed-meshheading:21216833-Heart Failure,
pubmed-meshheading:21216833-Hospitalization,
pubmed-meshheading:21216833-Humans,
pubmed-meshheading:21216833-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21216833-Kaplan-Meier Estimate,
pubmed-meshheading:21216833-Lipids,
pubmed-meshheading:21216833-Male,
pubmed-meshheading:21216833-Middle Aged,
pubmed-meshheading:21216833-Osteoprotegerin,
pubmed-meshheading:21216833-Predictive Value of Tests,
pubmed-meshheading:21216833-Proportional Hazards Models,
pubmed-meshheading:21216833-Pyrimidines,
pubmed-meshheading:21216833-Risk Assessment,
pubmed-meshheading:21216833-Risk Factors,
pubmed-meshheading:21216833-Sulfonamides,
pubmed-meshheading:21216833-Time Factors,
pubmed-meshheading:21216833-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
|
|
pubmed:affiliation |
Research Institute for Internal Medicine, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway. thor.ueland@medisin.uio.no
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
